Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Acyclovir + AdV-tk |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Acyclovir | Zovirax | Virorax|Cargosil|BW-248U|acycloguanosine|aclovir|aciclovir | Acyclovir is a synthetic analog of guanosine, which functions as an antiviral agent by inhibiting viral DNA polymerase (NCI Drug Dictionary). | |
AdV-tk | Aglatimagene besadenovec|GliAtak|ProstAtak|CAN-2409|CAN2409|Virafir | ADV-tk (aglatimagene besadenovec) is an engineered adenoviral vector expressing the herpes simplex virus thymidine kinase that sensitizes tumor cells to therapy with acyclic guanosine analogues (PMID: 26843484, PMID: 30883662). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02446093 | Phase II | AdV-tk + Valacyclovir Acyclovir + AdV-tk | Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma (PaTK02) | Active, not recruiting | USA | 1 |